Back to News
Market Impact: 0.4
Moderna Stock Pops, Taps Multi-Year High After Earnings
Source: schaeffersresearch.com
Corporate EarningsHealthcare & BiotechCompany FundamentalsAnalyst Estimates
Moderna reported third-quarter earnings of $0.38 per share and revenue of $1.3 billion, versus estimates for a $1.25-per-share loss and approximately $882 million in revenue. The stock was up 3.9% at $250.95 after the results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.65
Ticker Sentiment
MRNA0.80
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- Stocks making the biggest moves midday: Nvidia, Moderna, IonQ, Airbnb, Firefly Aerospace & more
- While biotech bets swing on trial data, this dividend payer gained 72% since 2024
- 5 Things Investors Need to Know About Friday's Markets
- Our top 10 things to watch in the stock market Friday
- Stocks making the biggest moves premarket: Moderna, Airbnb, Cloudflare, Affirm & more